{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:12:18Z","timestamp":1782141138425,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.pharep.2017.08.014","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T04:31:09Z","timestamp":1504153869000},"page":"184-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Therapeutic drug monitoring of digoxin\u201320 years of experience"],"prefix":"10.1007","volume":"70","author":[{"given":"Grzegorz","family":"Grze\u015bk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioleta","family":"Stolarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Kasprzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Krzy\u017canowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Szadujkis-Szadurska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Wici\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Grze\u015bk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"4","key":"10.1016\/j.pharep.2017.08.014_bib0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/pcad.2002.31591","volume":"44","author":"Eichhorn","year":"2002","journal-title":"Prog Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.pharep.2017.08.014_bib0010","first-page":"621","article-title":"Cardiotoxic plants (Polish)","volume":"62","author":"Szkolnicka","year":"2005","journal-title":"Przegl Lek"},{"key":"10.1016\/j.pharep.2017.08.014_bib0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0167-5273(93)90270-Q","article-title":"The chronic effects of long-term digoxin administration on Na+\/K(+)-ATPase activity in rat tissues","volume":"40","author":"Li","year":"1993","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharep.2017.08.014_bib0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0009-9236(97)90166-1","article-title":"Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions","volume":"61","author":"Sotaniemi","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharep.2017.08.014_bib0025","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM197105062841801","article-title":"Digitalis intoxication: a prospective clinical study with serum level correlations","volume":"284","author":"Beller","year":"1971","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.pharep.2017.08.014_bib0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0033-0620(84)90012-4","article-title":"Digitalis glycosides: mechanisms and manifestations of toxicity. Part I","volume":"26","author":"Smith","year":"1984","journal-title":"Prog Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.pharep.2017.08.014_bib0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0033-0620(84)90014-8","article-title":"Digitalis glycosides: mechanisms and manifestations of toxicity","volume":"26","author":"Smith","year":"1984","journal-title":"Part II. Prog Cardiovasc Dis"},{"key":"10.1016\/j.pharep.2017.08.014_bib0040","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"The Digitalis Investigation Group","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharep.2017.08.014_bib0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cardfail.2003.12.005","article-title":"Digitalis for treatment of congestive heart failure in patients in sinus rhythm: a systematic review and meta-analysis","volume":"10","author":"Hood","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.pharep.2017.08.014_bib0050","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","article-title":"Are hospitalized or ambulatory patients with heart failure treated in accordance with European society of cardiology guidelines? Evidence from 12 440 patients of the ESC heart failure long-term registry","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"27","key":"10.1016\/j.pharep.2017.08.014_bib0055","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2014","journal-title":"Eur Heart J"},{"issue":"May (5)","key":"10.1016\/j.pharep.2017.08.014_bib0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/eurjhf\/hft010","article-title":"Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial","volume":"15","author":"Gheorghiade","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pharep.2017.08.014_bib0065","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharep.2017.08.014_bib0070","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehi687","article-title":"Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial","volume":"27","author":"Ahmed","year":"2006","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.pharep.2017.08.014_bib0075","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jchf.2015.12.003","article-title":"Temporal trends of digoxin use in patients hospitalized with heart failure: analysis from the american heart association get with the guidelines-heart failure registry","volume":"4","author":"Patel","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.pharep.2017.08.014_bib0080","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa021266","article-title":"Sex-based differences in the effect of digoxin for the treatment of heart failure","volume":"347","author":"Rathore","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharep.2017.08.014_bib0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jacc.2005.02.091","article-title":"Relationship of serum digoxin concentration to mortality and morbidity in women in the Digitalis Investigation Group Trial","volume":"46","author":"Adams","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharep.2017.08.014_bib0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-200241050-00002","article-title":"How important are gender differences in pharmacokinetics","volume":"41","author":"Meibohm","year":"2002","journal-title":"Clin Pharmakokinet"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S173411401630305X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S173411401630305X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:20Z","timestamp":1752611840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2017.08.014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S173411401630305X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2017.08.014","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic drug monitoring of digoxin\u201320 years of experience","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2017.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}